Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Anal Bioanal Chem. 2014 Jul 31;406(25):6265–6274. doi: 10.1007/s00216-014-8037-8

Table 2.

A list of highly confident identifications of glycopeptides from the rhEPO with the predicted structures, glycosylation sites and the relative abundance from log2 (peak areas).

ID Glycan structure Relative abundance(%)
N24 N38 N83 O126
1 (Hex)0(HexNAc)1(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.4
2 (Hex)1(HexNAc)1(NeuAc)1(NeuGc)0(Deoxyhex)0 53.5
3 (Hex)1(HexNAc)1(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 2.3 0.5 0.0
4 (Hex)1(HexNAc)1(NeuAc)2(NeuGc)0(Deoxyhex)0 46.5
5 (Hex)1(HexNAc)1(NeuAc)4(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.2
6 (Hex)1(HexNAc)2(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 1.2
7 (Hex)1(HexNAc)2(NeuAc)3(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.3
8 (Hex)2(HexNAc)2(NeuAc)0(NeuGc)1(Deoxyhex)1+(Man)3(GlcNAc)2 0.1
9 (Hex)2(HexNAc)2(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 13.1 3.1
10 (Hex)2(HexNAc)2(NeuAc)2(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 28.7 6.2 1.1
11 (Hex)2(HexNAc)2(NeuAc)3(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.2
12 (Hex)2(HexNAc)2(NeuAc)3(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.5
13 (Hex)2(HexNAc)3(NeuAc)1(NeuGc)1(Deoxyhex)1+(Man)3(GlcNAc)2 0.5
14 (Hex)2(HexNAc)3(NeuAc)2(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 2.3 0.3
15 (Hex)2(HexNAc)3(NeuAc)2(NeuGc)2(Deoxyhex)0+(Man)3(GlcNAc)2 0.3
16 (Hex)3(HexNAc)3(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 10.0 4.3
17 (Hex)3(HexNAc)3(NeuAc)1(NeuGc)1(Deoxyhex)1+(Man)3(GlcNAc)2 0.2
18 (Hex)3(HexNAc)3(NeuAc)2(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 11.8 11.1 4.2
19 (Hex)3(HexNAc)3(NeuAc)3(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 7.2 2.7 3.0
20 (Hex)3(HexNAc)4(NeuAc)1(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.6
21 (Hex)3(HexNAc)4(NeuAc)2(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.4
22 (Hex)4(HexNAc)4(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 2.4
23 (Hex)4(HexNAc)4(NeuAc)2(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 4.3 10.4 7.3
24 (Hex)4(HexNAc)4(NeuAc)3(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.1
25 (Hex)4(HexNAc)4(NeuAc)3(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 1.2 10.5 9.7
26 (Hex)4(HexNAc)4(NeuAc)4(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 1.0 2.8 0.7
27 (Hex)4(HexNAc)5(NeuAc)3(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 1.1
28 (Hex)5(HexNAc)5(NeuAc)1(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.3 2.0 36.9
29 (Hex)5(HexNAc)5(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 1.9 0.6
30 (Hex)5(HexNAc)5(NeuAc)2(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 2.5 9.1
31 (Hex)5(HexNAc)5(NeuAc)3(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 3.5
32 (Hex)5(HexNAc)5(NeuAc)4(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.7 1.9
33 (Hex)6(HexNAc)6(NeuAc)1(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 1.3 15.6 6.1
34 (Hex)6(HexNAc)6(NeuAc)1(NeuGc)0Deoxyhex1+(Man)3(GlcNAc)2 2.8
35 (Hex)6(HexNAc)6(NeuAc)2(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.6 6.3 0.6
36 (Hex)6(HexNAc)6(NeuAc)3(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.2
37 (Hex)6(HexNAc)6(NeuAc)4(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 2.6 0.8
38 (Hex)7(HexNAc)7(NeuAc)0(NeuGc)2(Deoxyhex)0+(Man)3(GlcNAc)2 0.1
39 (Hex)7(HexNAc)7(NeuAc)1(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 2.3 9.1 17.8
40 (Hex)7(HexNAc)7(NeuAc)1(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.3
41 (Hex)7(HexNAc)7(NeuAc)2(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.2
42 (Hex)7(HexNAc)7(NeuAc)4(NeuGc)0(Deoxyhex)1+(Man)3(GlcNAc)2 0.1
43 (Hex)7(HexNAc)8(NeuAc)1(NeuGc)0Deoxyhex1+(Man)3(GlcNAc)2 0.6
44 (Hex)8(HexNAc)8(NeuAc)1(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.9
45 (Hex)8(HexNAc)8(NeuAc)2(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 0.1
46 (Hex)9(HexNAc)9(NeuAc)1(NeuGc)0(Deoxyhex)0+(Man)3(GlcNAc)2 3.8
total 100.0 100.0 100.0 100.0